Articles with the topic: featured

TRACK-HD reveals changes in HD mutation carriers, empowering future trials

TRACK-HD reveals changes in HD mutation carriers, empowering future trials

Follow-up data from TRACK-HD study proves that we have the tests we need to successfully run drug trials for HD

Prof Anne RosserDecember 05, 2011

HDAC inhibitors and a possible 'blood biomarker'

HDAC inhibitors and a possible 'blood biomarker'

HDAC inhibitors explained, plus how new HDAC-related Huntington's disease research might help us find biomarkers

Professor Ed WildOctober 14, 2011

Oz Buzz Video: Day 2

Oz Buzz Video: Day 2

The final day of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011

Dr Jeff CarrollSeptember 16, 2011

Oz Buzz Video: Day 1

Oz Buzz Video: Day 1

Day 1 of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011

Professor Ed WildSeptember 15, 2011

Ten golden rules for reading a scientific news story

Ten golden rules for reading a scientific news story

Avoid the hype: HDBuzz presents ten 'golden rules' for reading a news story or press release about Huntington's disea

Professor Ed WildSeptember 05, 2011

Stem cells and HD: past, present and future

Stem cells and HD: past, present and future

Stem cells - who needs 'em? Scientists make brain cells from skin cells. Could this help HD?

Dr Jeff CarrollAugust 08, 2011

KMO inhibitor drug improves lifespan of Huntington's disease mice

KMO inhibitor drug improves lifespan of Huntington's disease mice

Positive results from tests of a new 'KMO inhibiting' drug in Huntington's disease mice

Professor Ed WildJune 02, 2011

The genetic 'gray area' of Huntington's disease: what does it all mean?

The genetic 'gray area' of Huntington's disease: what does it all mean?

Intermediate alleles and reduced penetrance – the genetic 'gray area' of Huntington’s disease, explained

Dr Nayana LahiriApril 22, 2011

Dimebon fails in late-stage human HD clinical trial

Dimebon fails in late-stage human HD clinical trial

Dimebon fails to improve symptoms in HD patients in the HORIZON trial

Dr Jeff CarrollApril 11, 2011